Get the Stockscreener App
56.57
5.10%
-3.04
After Hours:
56.57
Globus Medical Inc stock is traded at $56.57, with a volume of 1.04M.
It is down -5.10% in the last 24 hours and down -3.20% over the past month.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
See More
Previous Close:
$59.61
Open:
$59.75
24h Volume:
1.04M
Relative Volume:
0.75
Market Cap:
$7.64B
Revenue:
$2.51B
Net Income/Loss:
$185.56M
P/E Ratio:
42.22
EPS:
1.34
Net Cash Flow:
$517.59M
1W Performance:
-6.46%
1M Performance:
-3.20%
6M Performance:
-20.30%
1Y Performance:
-18.94%
1-Day Range:
$56.50
$59.90
1-Week Range:
$56.50
$61.64
52-Week Range:
$51.79
$94.93
Globus Medical Inc Stock (GMED) Company Profile
Name
Globus Medical Inc
Sector
Industry
Phone
610-930-1800
Address
2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA
Compare GMED with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GMED
Globus Medical Inc
|
56.57 | 8.05B | 2.51B | 185.56M | 517.59M | 1.34 |
|
ABT
Abbott Laboratories
|
132.57 | 232.02B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
95.41 | 144.14B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.60 | 141.53B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.45 | 123.78B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.94 | 44.14B | 5.69B | 1.41B | 577.90M | 6.9828 |
Globus Medical Inc Stock (GMED) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-27-25 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-10-25 | Upgrade | BofA Securities | Underperform → Neutral |
| Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-07-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| May-20-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Mar-18-24 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-20-23 | Initiated | ROTH MKM | Buy |
| Sep-19-23 | Upgrade | Stifel | Hold → Buy |
| Mar-30-23 | Upgrade | Canaccord Genuity | Hold → Buy |
| Feb-13-23 | Downgrade | BofA Securities | Buy → Underperform |
| Feb-10-23 | Downgrade | BTIG Research | Buy → Neutral |
| Feb-10-23 | Downgrade | Loop Capital | Buy → Hold |
| Feb-10-23 | Downgrade | Needham | Buy → Hold |
| Feb-10-23 | Downgrade | Truist | Buy → Hold |
| Feb-10-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Apr-13-22 | Resumed | Truist | Buy |
| Mar-28-22 | Initiated | Wells Fargo | Overweight |
| Jan-04-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-13-21 | Upgrade | BofA Securities | Underperform → Buy |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| Oct-29-21 | Initiated | Loop Capital | Buy |
| Feb-18-21 | Resumed | Needham | Buy |
| Dec-08-20 | Initiated | Citigroup | Buy |
| Oct-20-20 | Initiated | Stifel | Hold |
| Aug-06-20 | Reiterated | Needham | Buy |
| Aug-06-20 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jul-21-20 | Initiated | Northland Capital | Market Perform |
| Jul-06-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-08-20 | Reiterated | Needham | Buy |
| Mar-18-20 | Upgrade | BTIG Research | Neutral → Buy |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Dec-12-19 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Aug-02-19 | Reiterated | Needham | Buy |
| May-24-19 | Downgrade | Wells Fargo | Outperform → Market Perform |
| May-03-19 | Reiterated | Needham | Buy |
| Feb-28-19 | Upgrade | UBS | Neutral → Buy |
| Jan-02-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Aug-02-18 | Reiterated | Needham | Buy |
| Jun-27-18 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jun-01-18 | Initiated | Cantor Fitzgerald | Overweight |
| May-03-18 | Reiterated | Needham | Buy |
| Apr-04-18 | Upgrade | Needham | Hold → Buy |
View All
Globus Medical Inc Stock (GMED) Latest News
What drives Globus Medical Inc GM0N stock priceMarket Insider Reports & Amplify Gains With Picks - earlytimes.in
Myriad Genetics, Omnicell, Globus Medical, Repligen, and Teleflex Stocks Trade Down, What You Need To Know - Yahoo
Is Globus Medical Inc. (GM0N) stock ideal for retirement investors2025 Valuation Update & Long-Term Growth Stock Strategies - newser.com
RBC Cuts Price Target on Globus Medical to $88 From $95, Keeps Outperform Rating - MarketScreener
Will Globus Medical Inc. Class stock rise with strong economy2025 Market WrapUp & AI Based Buy and Sell Signals - newser.com
Applying Wyckoff theory to Globus Medical Inc. stock2025 Analyst Calls & Free Real-Time Market Sentiment Alerts - newser.com
What analysts say about Globus Medical Inc GM0N stockPrice Support Zones & High Profit Market Ideas - earlytimes.in
A Quick Look at Today's Ratings for Globus Medical(GMED.US), With a Forecast Between $82 to $100 - 富途牛牛
Volatility clustering patterns for Globus Medical Inc.2025 EndofYear Setup & Safe Entry Zone Tips - newser.com
Globus Medical's (GMED) Hold (C) Rating Reiterated at Weiss Ratings - MarketBeat
Globus Medical Experiences Revision in Stock Evaluation Amid Mixed Market Signals - Markets Mojo
Can Globus Medical’s (GMED) Global Expansion Unlock Sustainable Returns for Investors? - Sahm
Winners And Losers Of Q2: Globus Medical (NYSE:GMED) Vs The Rest Of The Medical Devices & SuppliesSpecialty Stocks - FinancialContent
Has Globus Medical Inc. formed a bullish divergenceJuly 2025 Update & Breakout Confirmation Trade Signals - newser.com
Top 3 Stocks Generating Strong Free Cash Flow | Stride, Globus Medical, EXLNews and Statistics - IndexBox
Comparing Globus Medical Inc. in custom built stock radarsJuly 2025 PostEarnings & AI Based Buy/Sell Signal Reports - newser.com
Is Globus Medical Inc. Class stock supported by free cash flowProfit Target & Fast Gain Swing Trade Alerts - newser.com
Globus Medical (GMED): Evaluating Valuation After New Products, Growth, and ROIC Slowdown - Sahm
Globus Medical, Inc. $GMED Holdings Lowered by Vaughan Nelson Investment Management L.P. - MarketBeat
Globus Medical (GMED): Assessing Valuation as Growth and Innovation Raise Questions on Future Returns - Yahoo Finance
Will Globus Medical Inc. see short term momentum2025 Price Targets & Technical Pattern Based Buy Signals - newser.com
Why Globus Medical Inc. (GM0N) stock is a strong buy callBond Market & Weekly High Potential Stock Alerts - newser.com
2 Reasons to Watch GMED and 1 to Stay Cautious - Yahoo Finance
Globus acquires US medical device company Nevro - MSN
Will Globus Medical Inc. Class stock deliver compounding returnsWeekly Investment Summary & Stock Market Timing Techniques - newser.com
Park Avenue Securities LLC Makes New $513,000 Investment in Globus Medical, Inc. $GMED - MarketBeat
What analysts say about Globus Medical Inc stockAnalyst Downgrades & High Profit Market Growth - earlytimes.in
Here's Why Globus Medical (GMED) is a Strong Value Stock - Yahoo Finance
Globus Medical (NYSE:GMED) Shareholders Have Endured a 22% Loss From Investing in the Stock a Year Ago - 富途牛牛
Washington Capital Management Inc. Makes New Investment in Globus Medical, Inc. $GMED - MarketBeat
Globus Medical, Inc. (GMED) Stock Analysis: Discovering A 44% Potential Upside - DirectorsTalk Interviews
Robotic Neurosurgery Market Analysis and Forecast Report - GlobeNewswire
Fort Washington Investment Advisors Inc. OH Has $22.75 Million Stake in Globus Medical, Inc. $GMED - MarketBeat
Robotic Neurosurgery Market Analysis and Forecast Report 2025-2035, with Profiles of Brainlab, Renishaw, Zimmer Biomet, Medical Microinstruments, Monteris Medical, Medtronic, Globus Medical, & Accuray - Yahoo Finance
Globus Medical Inc Stock (GMED) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.83%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):